Roche divarasib cuts death risk by 44% vs first-gen KRAS inhibitors
Immatics reports PRAME bispecific and cell therapy data at ESMO 2026
Celcuity VIKTORIA-1 data show gedatolisib doubles PFS in subgroup
Darolutamide cuts metastasis risk by 58% in high-risk prostate cancer
Gesynta Pharma completes NOVA trial enrolment ahead of schedule
Optimi Health completes MDMA batch for Phase 3 PTSD trial and export
Myriad Genetics sells prenatal testing unit to Labcorp for $210m
ITM radiopharmaceutical dose-response data backs ITM-11 in GEP-NETs
AltruBio Phase 2a UC data show dose-response signal for ALTB-268
F2G olorofim matches AmBisome in Phase 3 invasive aspergillosis trial
Medicovestor wins FDA Fast Track for ADC MC001 in pancreatic cancer
Circle CVI joins EXIT-CVD consortium to advance AI cardiac imaging
Telix Pharmaceuticals posts $245m Q3 revenue, closes ITM merger
Ascentage Pharma's lisaftoclax wins China BTD for first-line CLL/SLL
PolarityBio SkinTE Phase 3 trial wins top SAWC abstract award
